메뉴 건너뛰기
Annals of Internal Medicine
Volumn 160, Issue 8, 2014, Pages 581-
Triple therapy for hepatitis C virus infection in patients receiving hemodialysis
Author keywords

[No Author keywords available]
Indexed keywords

BOCEPREVIR; ERYTHROPOIETIN; PEGINTERFERON ALPHA2A; RIBAVIRIN; TELAPREVIR; VIRUS RNA; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE;
EID: 84898927227     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L14-5008-3     Document Type: Letter
Times cited : (3)
References (5)
  • 1
    • 84984584179 scopus 로고    scopus 로고
    • Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
    • PMID: 24297189
    • Liu CH, Huang CF, Liu CJ, Dai CY, Liang CC, Huang JF, et al. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Ann Intern Med. 2013;159:729-38. [PMID: 24297189]
    • (2013) Ann Intern Med. , vol.159 , pp. 729-738
    • Liu, C.H.1    Huang, C.F.2    Liu, C.J.3    Dai, C.Y.4    Liang, C.C.5    Huang, J.F.6
  • 2
    • 78650307256 scopus 로고    scopus 로고
    • Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand
    • PMID: 20861806
    • Scott DR, Wong JK, Spicer TS, Dent H, Mensah FK, McDonald S, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation. 2010;90:1165-71. [PMID: 20861806]
    • (2010) Transplantation , vol.90 , pp. 1165-1171
    • Scott, D.R.1    Wong, J.K.2    Spicer, T.S.3    Dent, H.4    Mensah, F.K.5    McDonald, S.6
  • 3
    • 79953176289 scopus 로고    scopus 로고
    • HCV RESPOND-2 Investigators. Boceprevir for previously treated chronic HCV genotype 1 infection
    • PMID: 21449784
    • Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, et al; HCV RESPOND-2 Investigators. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364:1207-17. [PMID: 21449784]
    • (2011) N Engl J Med. , vol.364 , pp. 1207-1217
    • Bacon, B.R.1    Gordon, S.C.2    Lawitz, E.3    Marcellin, P.4    Vierling, J.M.5    Zeuzem, S.6
  • 4
    • 84864756342 scopus 로고    scopus 로고
    • Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function
    • PMID: 22799589
    • Treitel M, Marbury T, Preston RA, Triantafyllou I, Feely W, O'Mara E, et al. Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function. Clin Pharmacokinet. 2012;51:619-28. [PMID: 22799589]
    • (2012) Clin Pharmacokinet. , vol.51 , pp. 619-628
    • Treitel, M.1    Marbury, T.2    Preston, R.A.3    Triantafyllou, I.4    Feely, W.5    O'Mara, E.6
  • 5
    • 84872403051 scopus 로고    scopus 로고
    • Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: Is it feasible?
    • PMID: 23149155
    • Dumortier J, Guillaud O, Gagnieu MC, Janbon B, Juillard L, Morelon E, et al. Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible? J Clin Virol. 2013;56:146-9. [PMID: 23149155]
    • (2013) J Clin Virol , vol.56 , pp. 146-149
    • Dumortier, J.1    Guillaud, O.2    Gagnieu, M.C.3    Janbon, B.4    Juillard, L.5    Morelon, E.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.